Skip to main content

ExodusPoint Capital Management, LP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1736225 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,141,740
+3179.4% QoQ
Ownership
0.444%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names. ESPR ranks #18 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 1,141,740
2025-12-31 34,815
2024-09-30 262,134
2024-06-30 106,722
2024-03-31 83,400
2023-03-31 257,584
2022-12-31 1,171,799
2022-09-30 364,951
2022-06-30 24,007
2022-03-31 42,506
2021-12-31 14,079
2021-09-30 63,460